These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20148330)

  • 21. Global stability in a tuberculosis model of imperfect treatment with age-dependent latency and relapse.
    Ren S
    Math Biosci Eng; 2017 Oct/Dec 1; 14(5-6):1337-1360. PubMed ID: 29161864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global dynamics of a general class of multi-group epidemic models with latency and relapse.
    Feng X; Teng Z; Zhang F
    Math Biosci Eng; 2015 Feb; 12(1):99-115. PubMed ID: 25811334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A spatial SIS model in heterogeneous environments with vary advective rate.
    An X; Song X
    Math Biosci Eng; 2021 Jun; 18(5):5449-5477. PubMed ID: 34517496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic analysis of a fractional-order delayed model for hepatitis B virus with CTL immune response.
    Shi R; Lu T; Wang C
    Virus Res; 2020 Feb; 277():197841. PubMed ID: 31887328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The global stability of an SIRS model with infection age.
    Chen Y; Yang J; Zhang F
    Math Biosci Eng; 2014 Jun; 11(3):449-69. PubMed ID: 24506548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Threshold dynamics in an SEIRS model with latency and temporary immunity.
    Yuan Y; Bélair J
    J Math Biol; 2014 Oct; 69(4):875-904. PubMed ID: 23989861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis on a diffusive SIS epidemic system with linear source and frequency-dependent incidence function in a heterogeneous environment.
    Suo JZ; Li B
    Math Biosci Eng; 2019 Oct; 17(1):418-441. PubMed ID: 31731359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ustekinumab use in patients with severe psoriasis co-infected with hepatitis B and/or C.
    Siegel SAR; Winthrop KL; Ehst BD; Ortega Loayza A
    Br J Dermatol; 2019 May; 180(5):1232-1233. PubMed ID: 30460766
    [No Abstract]   [Full Text] [Related]  

  • 29. Global dynamics of an SEIR epidemic model with saturating contact rate.
    Zhang J; Ma Z
    Math Biosci; 2003 Sep; 185(1):15-32. PubMed ID: 12900140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of variability of reproductive ageing and rate on childhood infectious disease prevention and control: insights from stage-structured population models.
    Su Q; Wu J
    Math Biosci Eng; 2020 Nov; 17(6):7671-7691. PubMed ID: 33378914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global dynamics of a vaccination model for infectious diseases with asymptomatic carriers.
    Manyombe ML; Mbang J; Lubuma J; Tsanou B
    Math Biosci Eng; 2016 Aug; 13(4):813-840. PubMed ID: 27775386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The transmission dynamic and optimal control of acute and chronic hepatitis B.
    Khan T; Zaman G; Chohan MI
    J Biol Dyn; 2017 Dec; 11(1):172-189. PubMed ID: 27852159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global stability of an epidemic model with delay and general nonlinear incidence.
    McCluskey CC
    Math Biosci Eng; 2010 Oct; 7(4):837-50. PubMed ID: 21077711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Threshold dynamics of an SIR epidemic model with hybrid of multigroup and patch structures.
    Kuniya T; Muroya Y; Enatsu Y
    Math Biosci Eng; 2014 Dec; 11(6):1375-93. PubMed ID: 25365599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses.
    Zhou K; Contag C; Whitaker E; Terrault N
    Lancet Gastroenterol Hepatol; 2019 Mar; 4(3):227-238. PubMed ID: 30679109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mathematical model analysis of effective intervention strategies on transmission dynamics of hepatitis B virus.
    Wodajo FA; Gebru DM; Alemneh HT
    Sci Rep; 2023 May; 13(1):8737. PubMed ID: 37253760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global stability mathematical analysis for virus transmission model with latent age structure.
    Ren S; Li L
    Math Biosci Eng; 2022 Jan; 19(4):3337-3349. PubMed ID: 35341254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HBsAg loss in chronic hepatitis B: pointers to the benefits of curative therapy.
    Dusheiko G; Wang B; Carey I
    Hepatol Int; 2016 Sep; 10(5):727-9. PubMed ID: 27246696
    [No Abstract]   [Full Text] [Related]  

  • 39. Global analysis of a mathematical model for Hepatitis C virus transmissions.
    Shi R; Cui Y
    Virus Res; 2016 Jun; 217():8-17. PubMed ID: 26940946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B surface antigen quantification: not what it seems on the surface.
    Locarnini S; Bowden S
    Hepatology; 2012 Aug; 56(2):411-4. PubMed ID: 22454331
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.